Steris plc logo

Steris plc (STE)

Market Closed
12 Aug, 20:00
NYSE NYSE
$
243. 76
+2.14
+0.89%
$
23.89B Market Cap
39.65 P/E Ratio
2.08% Div Yield
334,788 Volume
8.66 Eps
$ 241.62
Previous Close
Day Range
241.28 243.91
Year Range
200.98 252.79
Want to track STE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 83 days

Summary

STE closed today higher at $243.76, an increase of 0.89% from yesterday's close, completing a monthly increase of 7.63% or $17.29. Over the past 12 months, STE stock gained 18.44%.
STE pays dividends to its shareholders, with the most recent payment made on Jun 26, 2025. The next announced payment will be in In 1 month on Sep 26, 2025 for a total of $0.63.
The last earnings report, released on Aug 06, 2025, missed the consensus estimates by -2.32%. On average, the company has fell short of earnings expectations by -2.32%, based on the last three reports. The next scheduled earnings report is due on Nov 04, 2025.
Steris plc has completed 2 stock splits, with the recent split occurring on Aug 25, 1998.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on NYSE (USD).

STE Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.
Here's Why Steris (STE) is a Strong Growth Stock

Here's Why Steris (STE) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 1 day ago
Understanding Steris (STE) Reliance on International Revenue

Understanding Steris (STE) Reliance on International Revenue

Examine the evolution of Steris' (STE) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

Zacks | 1 day ago
STERIS plc (STE) Q1 2026 Earnings Call Transcript

STERIS plc (STE) Q1 2026 Earnings Call Transcript

STERIS plc (NYSE:STE ) Q1 2026 Earnings Conference Call August 7, 2025 8:30 AM ET Company Participants Daniel A. Carestio - President, CEO & Director Julie Winter - Vice President of Investor Relations & Corporate Communications Michael J.

Seekingalpha | 5 days ago

Steris plc Dividends

Steris plc logo
STE In 3 weeks
Announced
Quarterly
$0.63 Per Share
Steris plc logo
STE 2 months ago
Paid
Quarterly
$0.57 Per Share
Steris plc logo
STE 5 months ago
Paid
Quarterly
$0.57 Per Share
Steris plc logo
STE 8 months ago
Paid
Quarterly
$0.57 Per Share
Steris plc logo
STE 11 months ago
Paid
Quarterly
$0.57 Per Share

Steris plc Earnings

5 Nov 2025 (In 2 months) Date
2.39
Cons. EPS
-
EPS
4 Nov 2025 (In 2 months) Date
2.37
Cons. EPS
-
EPS
6 Aug 2025 Date
2.32
Cons. EPS
-
EPS
6 Aug 2025 Date
2.32
Cons. EPS
-
EPS
5 Aug 2025 Date
2.32
Cons. EPS
-
EPS
Steris plc logo
STE In 3 weeks
Announced
Quarterly
$0.63 Per Share
Steris plc logo
STE 2 months ago
Paid
Quarterly
$0.57 Per Share
Steris plc logo
STE 5 months ago
Paid
Quarterly
$0.57 Per Share
Steris plc logo
STE 8 months ago
Paid
Quarterly
$0.57 Per Share
Steris plc logo
STE 11 months ago
Paid
Quarterly
$0.57 Per Share
5 Nov 2025 (In 2 months) Date
2.39
Cons. EPS
-
EPS
4 Nov 2025 (In 2 months) Date
2.37
Cons. EPS
-
EPS
6 Aug 2025 Date
2.32
Cons. EPS
-
EPS
6 Aug 2025 Date
2.32
Cons. EPS
-
EPS
5 Aug 2025 Date
2.32
Cons. EPS
-
EPS

Steris plc (STE) FAQ

What is the stock price today?

The current price is $243.76.

On which exchange is it traded?

Steris plc is listed on NYSE.

What is its stock symbol?

The ticker symbol is STE.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.08%.

What is its market cap?

As of today, the market cap is 23.89B.

What is the earnings per share?

The EPS is 2.37.

When is the next earnings date?

The next earnings report will release on Nov 04, 2025.

Has Steris plc ever had a stock split?

Steris plc had 2 splits and the recent split was on Aug 25, 1998.

Steris plc Profile

Medical - Devices Industry
Healthcare Sector
Daniel A. Carestio CEO
NYSE Exchange
G8473T100 Cusip
IE Country
18,000 Employees
4 Sep 2025 Last Dividend
25 Aug 1998 Last Split
1 Jun 1992 IPO Date

Overview

STERIS plc is a leading global provider of infection prevention products and services. With its operations spanning across four main segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental, STERIS caters to a wide range of needs in the medical and pharmaceutical fields. From offering cleaning chemistries and sterilization products to providing comprehensive equipment management and maintenance services, the company stands as a vital player in the mission to maintain sterility and prevent infection worldwide. Founded in 1985 and headquartered in Dublin, Ireland, STERIS has built a robust presence around the globe, servicing hospitals, healthcare providers, and pharmaceutical manufacturers with its innovative solutions and services.

Products and Services

  • Healthcare Segment

    Provides a variety of products and services essential for sterile processing departments and operating rooms. This includes cleaning chemistries, sterility assurance products, automated endoscope reprocessing systems, surgical tables, and lights, among other capital equipment. STERIS also offers comprehensive equipment management services, including installation, maintenance, upgrade, repair, and troubleshooting, as well as preventive maintenance programs, instrument, and endoscope repair and maintenance, and consulting for process improvement.

  • Applied Sterilization Technologies Segment

    Offers contract sterilization and testing services to medical device and pharmaceutical manufacturers. With around 50 contract sterilization and laboratory facilities, STERIS supports clients by ensuring their products meet strict sterility standards through a variety of sterilization methods.

  • Life Sciences Segment

    Focused on the design, manufacturing, and sale of consumable products like formulated cleaning chemistries, and equipment including sterility assurance products, sterilizers, and washer disinfectors. Similar to the Healthcare segment, the Life Sciences division provides equipment installation, maintenance, upgrade, and repair services, alongside preventive maintenance and repair services tailored for the life sciences industry.

  • Dental Segment

    Delivers a range of products for dental offices including hand and electric-powered dental instruments, infection control products, personal protective equipment, and water quality products. These offerings are aimed at enhancing infection prevention practices within the dental suite, ensuring safety and compliance in dental care operations.

Contact Information

Address: 70 Sir John Rogerson's Quay
Phone: 353 1 232 2000